Tag Archives: USPTO

Eurand v. Mylan –A “School Of Obviousness”

Posted on April 20, 2012 by Warren Woessner

When I read the April 16th decision (App. No. 2011-1399, -1409 (Fed. Cir. April 16, 2012)) (a copy is available at the end of this post) in which a Fed. Cir. panel of Newman, O’Malley and Reyna reversed a district … Continue reading →

Prometheus Q/A – Which Side Are You On?

Posted on April 12, 2012 by Warren Woessner

A guest post from Robin Chadwick of SLW. During the three weeks since the Supreme Court ruled that certain diagnostic claims are not eligible for patenting, four other patent cases have been impacted by this ruling. The Court is shaping … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged Patent Law, Prometheus, robin chadwick, Supreme Court, USPTO | 1 Comment

USPTO Encourages Prosecution After Final – Sort of

Posted on April 4, 2012 by Warren Woessner

Although entry of any amendments after final rejection has always be discretionary with Examiners, for pretty much my entire career, I have had good luck continuing prosecution after final rejection – sometimes filing multiple Rule 116 amendments or making multiple … Continue reading →

Posted in USPTO Practice and Policy | Tagged RCE, Rule 116 Amendment, USPTO, Warren Woessner | 1 Comment

PTO To Biotech Examiners – We’ll Get Back To You!

Posted on March 26, 2012 by Warren Woessner

On March 21, 2012, Andrew H Hirschfield, Associate Commissioner for Patent Examination Policy, sent a short memo to the Patent Examining Corps to inform them about the decision in Prometheus v. Mayo. The “preliminary guidance” that was provided included a … Continue reading →